Independent directory Public ClinicalTrials.gov records United States
ClinicalTrials.gov record
Terminated Phase 3 Interventional Results available

An Extension To The B1451027 Protocol To Evaluate The Long Term Safety And Tolerability Of Dimebon In Patients With Alzheimer's Disease

ClinicalTrials.gov ID: NCT00939783

Public ClinicalTrials.gov record NCT00939783. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.

ClinicalTrials.gov public records Last synced Jun 25, 2026, 3:47 PM EDT

Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.

Official title

An Open Label Extension To The B1451027 Protocol To Evaluate The Long Term Safety And Tolerability Of Dimebon (PF 01913539) In Patients With Alzheimer's Disease

Study identification

NCT ID
NCT00939783
Recruitment status
Terminated
Study type
Interventional
Phase
Phase 3
Lead sponsor
Pfizer
Industry
Enrollment
649 participants

Conditions and interventions

Interventions

  • Dimebon Drug

Drug

Eligibility (public fields only)

Age range
50 Years and older
Sex
All
Healthy volunteers
Healthy volunteers not accepted

This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.

Study timeline

Start date
Aug 31, 2009
Primary completion
Jul 31, 2010
Completion
Jul 31, 2010
Last update posted
Nov 13, 2012

2009 – 2010

United States locations

U.S. sites
84
U.S. states
32
U.S. cities
80
Facility City State ZIP Site status
Pfizer Investigational Site Mobile Alabama 36608
Pfizer Investigational Site Northport Alabama 35476
Pfizer Investigational Site Little Rock Arkansas 72205
Pfizer Investigational Site Oceanside California 92056
Pfizer Investigational Site San Diego California 92123
Pfizer Investigational Site Santa Rosa California 95405
Pfizer Investigational Site Pueblo Colorado 81001
Pfizer Investigational Site Hockessin Delaware 19707
Pfizer Investigational Site Bradenton Florida 34205
Pfizer Investigational Site Brooksville Florida 34601
Pfizer Investigational Site Clearwater Florida 33756
Pfizer Investigational Site Daytona Beach Florida 32114
Pfizer Investigational Site Fort Myers Florida 33912
Pfizer Investigational Site Fort Walton Beach Florida 32547
Pfizer Investigational Site Maitland Florida 32751
Pfizer Investigational Site Melbourne Florida 32901
Pfizer Investigational Site Naples Florida 34102
Pfizer Investigational Site Ocala Florida 34471
Pfizer Investigational Site Orlando Florida 32806
Pfizer Investigational Site Plant City Florida 33563
Pfizer Investigational Site Port Charlotte Florida 33952
Pfizer Investigational Site St. Petersburg Florida 33709
Pfizer Investigational Site St. Petersburg Florida 33713
Pfizer Investigational Site Tampa Florida 33606
Pfizer Investigational Site Atlanta Georgia 30308
Pfizer Investigational Site Burr Ridge Illinois 60527
Pfizer Investigational Site Elk Grove Village Illinois 60007
Pfizer Investigational Site Elkhart Indiana 46514
Pfizer Investigational Site Evansville Indiana 47714
Pfizer Investigational Site Fort Wayne Indiana 46805
Pfizer Investigational Site Greenfield Indiana 46140-2834
Pfizer Investigational Site Prairie Village Kansas 66206
Pfizer Investigational Site Wichita Kansas 67207
Pfizer Investigational Site Lake Charles Louisiana 70601
Pfizer Investigational Site New Orleans Louisiana 70114
Pfizer Investigational Site Shreveport Louisiana 71105
Pfizer Investigational Site Hyannis Massachusetts 02601
Pfizer Investigational Site Flowood Mississippi 39232
Pfizer Investigational Site Olive Branch Mississippi 38654
Pfizer Investigational Site Springfield Missouri 65807
Pfizer Investigational Site Great Falls Montana 59405
Pfizer Investigational Site Eatontown New Jersey 07724
Pfizer Investigational Site Oakhurst New Jersey 07755
Pfizer Investigational Site Toms River New Jersey 08755
Pfizer Investigational Site Albuquerque New Mexico 87109
Pfizer Investigational Site Amherst New York 14226
Pfizer Investigational Site Buffalo New York 14211
Pfizer Investigational Site Buffalo New York 14215
Pfizer Investigational Site Orchard Park New York 14127
Pfizer Investigational Site Syracuse New York 13210
Pfizer Investigational Site Charlotte North Carolina 28211
Pfizer Investigational Site Raleigh North Carolina 27612
Pfizer Investigational Site Winston-Salem North Carolina 27103
Pfizer Investigational Site Fargo North Dakota 58103
Pfizer Investigational Site Fargo North Dakota 58104
Pfizer Investigational Site Cincinnati Ohio 45227
Pfizer Investigational Site Oklahoma City Oklahoma 73112
Pfizer Investigational Site Portland Oregon 97210
Pfizer Investigational Site Altoona Pennsylvania 16602
Pfizer Investigational Site Beaver Pennsylvania 15009
Pfizer Investigational Site Bridgeville Pennsylvania 15017
Pfizer Investigational Site Grove City Pennsylvania 16127
Pfizer Investigational Site Indiana Pennsylvania 15701
Pfizer Investigational Site Norristown Pennsylvania 19403
Pfizer Investigational Site Scotland Pennsylvania 17254
Pfizer Investigational Site Upper Saint Clair Pennsylvania 15241
Pfizer Investigational Site Charleston South Carolina 29425
Pfizer Investigational Site Greer South Carolina 29651
Pfizer Investigational Site Murrells Inlet South Carolina 29576
Pfizer Investigational Site North Charleston South Carolina 29406
Pfizer Investigational Site Orangeburg South Carolina 29118
Pfizer Investigational Site Sioux Falls South Dakota 57105
Pfizer Investigational Site Franklin Tennessee 37067
Pfizer Investigational Site Knoxville Tennessee 37920
Pfizer Investigational Site Carrollton Texas 75007
Pfizer Investigational Site Fort Worth Texas 76104
Pfizer Investigational Site Fort Worth Texas 76117
Pfizer Investigational Site Grand Prairie Texas 75050
Pfizer Investigational Site Lake Jackson Texas 77566
Pfizer Investigational Site Williamsburg Virginia 23185
Pfizer Investigational Site Kirkland Washington 98033
Pfizer Investigational Site Spokane Washington 99216
Pfizer Investigational Site Charleston West Virginia 25304
Pfizer Investigational Site La Crosse Wisconsin 54601

Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.

Non-U.S. locations

This page focuses on the U.S. directory. The official record also lists 21 non-U.S. sites.

About this trial record page

What this page shows
Public field values for ClinicalTrials.gov record NCT00939783, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
What this page does not do
No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
Where the data comes from
Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
Last refresh
Last update posted Nov 13, 2012 · Synced Jun 25, 2026

Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.

Open the official record

The complete protocol, eligibility criteria, and contact information for NCT00939783 live on ClinicalTrials.gov.

View official ClinicalTrials.gov record →